Generix SA: valuation
What the market value assumes, and what the company's own statements and its peers' prices would put it at. Every assumption is yours to change.
Cash-flow value
The newest statements on file are more than two years old.
Your own DCF model
A full discounted-cash-flow model of Generix SA, started from its filings: revenue growth and margins year by year, bear, base and bull cases, the WACC and its parts, sensitivity tables and a value per share against the dated market price. Save it, share it with your team or by a read-only link.
Open the DCF modelThe statements it starts from
USD millions at each year's exchange rate; free cash flow = cash from operations less capital spending.
| Fiscal year | Revenue | Net income | Cash from operations | Capital spending | Free cash flow | Net debt | Source |
|---|---|---|---|---|---|---|---|
| FY2021to Mar 31, 2022 | $94 M | $4 M | $13 M | $1 M | $12 M | — | ESEF annual report |
| FY2020to Mar 31, 2021 | $100 M | $5 M | $14 M | $2 M | $12 M | — | ESEF annual report |
| FY2019to Mar 31, 2020 | — | — | — | — | — | — | ESEF annual report |